Desmond G. Powe

6.5k total citations · 1 hit paper
63 papers, 5.2k citations indexed

About

Desmond G. Powe is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Desmond G. Powe has authored 63 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 25 papers in Cancer Research and 24 papers in Molecular Biology. Recurrent topics in Desmond G. Powe's work include Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (12 papers) and Cancer Cells and Metastasis (9 papers). Desmond G. Powe is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (12 papers) and Cancer Cells and Metastasis (9 papers). Desmond G. Powe collaborates with scholars based in United Kingdom, Egypt and Germany. Desmond G. Powe's co-authors include Ian O. Ellis, Andrew R. Green, Andrew H.S. Lee, Emma C. Paish, R. Douglas Macmillan, Emad A. Rakha, Sahar Mahmoud, Matthew J. Grainge, Hany Onsy Habashy and Frank Entschladen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Desmond G. Powe

62 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-Infiltrating CD8⁺Lymphocytes Predict Clinical Outcome in Breast Cancer

2011 1.1k citations Sahar Mahmoud, Emma C. Paish et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Desmond G. Powe United Kingdom	36	2.6k	1.8k	1.5k	878	669	63	5.2k
Pnina Brodt Canada	46	2.5k 1.0×	2.2k 1.3×	3.2k 2.1×	1.1k 1.3×	260 0.4×	115	6.8k
Weiping Shu United States	16	3.8k 1.5×	2.2k 1.3×	4.4k 2.9×	719 0.8×	363 0.5×	25	7.6k
Roger R. Gomis Spain	30	2.5k 1.0×	1.6k 0.9×	3.4k 2.2×	544 0.6×	289 0.4×	67	6.0k
Anna Bagnato Italy	46	1.4k 0.6×	1.0k 0.6×	3.3k 2.2×	564 0.6×	315 0.5×	124	6.2k
Brian Bierie United States	31	3.6k 1.4×	1.7k 1.0×	4.4k 2.9×	1.2k 1.3×	344 0.5×	38	7.1k
Cristina Nadal Spain	17	2.3k 0.9×	1.3k 0.7×	2.2k 1.4×	475 0.5×	312 0.5×	42	4.3k
Marta Sevillano Spain	13	2.9k 1.1×	1.0k 0.6×	1.9k 1.3×	940 1.1×	540 0.8×	14	4.3k
Thomas Karn Germany	37	2.2k 0.8×	1.7k 0.9×	2.3k 1.5×	794 0.9×	392 0.6×	141	4.9k
Mar Iglesias Spain	27	3.9k 1.5×	1.5k 0.9×	2.6k 1.7×	1.2k 1.4×	882 1.3×	94	6.6k
Daniele V. F. Tauriello Netherlands	19	3.0k 1.2×	1.1k 0.6×	2.3k 1.5×	1.2k 1.3×	548 0.8×	34	4.9k

Countries citing papers authored by Desmond G. Powe

Since Specialization

Citations

This map shows the geographic impact of Desmond G. Powe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Desmond G. Powe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Desmond G. Powe more than expected).

Fields of papers citing papers by Desmond G. Powe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Desmond G. Powe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Desmond G. Powe. The network helps show where Desmond G. Powe may publish in the future.

Co-authorship network of co-authors of Desmond G. Powe

This figure shows the co-authorship network connecting the top 25 collaborators of Desmond G. Powe. A scholar is included among the top collaborators of Desmond G. Powe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Desmond G. Powe. Desmond G. Powe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coveney, Clare, David J. Boocock, Sarah Wagner, et al.. (2020). β2-Adrenergic Signalling Promotes Cell Migration by Upregulating Expression of the Metastasis-Associated Molecule LYPD3. Biology. 9(2). 39–39. 29 indexed citations

Vadakekolathu, Jayakumar, Catherine Johnson, Anne Schneider, et al.. (2018). MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer. Cell Death and Disease. 9(3). 344–344. 29 indexed citations

Powe, Desmond G., et al.. (2013). Norepinephrine inhibits the migratory activity of pancreatic cancer cells. Experimental Cell Research. 319(12). 1744–1758. 18 indexed citations

Rondón, Carmen, Paloma Campo, Alkis Togias, et al.. (2012). Local allergic rhinitis: Concept, pathophysiology, and management. Journal of Allergy and Clinical Immunology. 129(6). 1460–1467. 195 indexed citations

Burns, Paul, Desmond G. Powe, & Nick S. Jones. (2011). Idiopathic rhinitis. Current Opinion in Otolaryngology & Head & Neck Surgery. 20(1). 1–8. 13 indexed citations

Paish, Emma C., Emad A. Rakha, Desmond G. Powe, et al.. (2011). EpCAM expression is an indicator of recurrence in basal-like breast cancer. Breast Cancer Research and Treatment. 133(2). 575–582. 22 indexed citations

Habashy, Hany Onsy, Desmond G. Powe, Tarek M. Abdel-Fatah, et al.. (2011). A review of the biological and clinical characteristics of luminal‐like oestrogen receptor‐positive breast cancer. Histopathology. 60(6). 854–863. 19 indexed citations

Barros, F., Desmond G. Powe, Ian O. Ellis, & Andrew R. Green. (2010). Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments. Histopathology. 56(5). 560–572. 58 indexed citations

Albasri, Abdulkader M., Mohammed A. Aleskandarany, Ahmed Benhasouna, et al.. (2010). CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosis. Breast Cancer Research and Treatment. 126(1). 47–54. 41 indexed citations

10.

Kwok, T’ng Chang, Emad A. Rakha, Andrew H.S. Lee, et al.. (2010). Histological grading of breast cancer on needle core biopsy: the role of immunohistochemical assessment of proliferation. Histopathology. 57(2). 212–219. 36 indexed citations

11.

Mahmoud, Sahar, Emma C. Paish, Desmond G. Powe, et al.. (2010). An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer. Breast Cancer Research and Treatment. 127(1). 99–108. 143 indexed citations

12.

Habashy, Hany Onsy, Desmond G. Powe, Enrico Glaab, et al.. (2010). RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype. Breast Cancer Research and Treatment. 128(2). 315–326. 39 indexed citations

13.

Powe, Desmond G., Hany Onsy Habashy, Tarek M.A. Abdel-Fatah, et al.. (2009). Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification. Breast Cancer Research. 11(6). R90–R90. 38 indexed citations

14.

Rakha, Emad A., Somaia Elsheikh, Mohammed A. Aleskandarany, et al.. (2009). Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes. Clinical Cancer Research. 15(7). 2302–2310. 394 indexed citations

15.

Habashy, Hany Onsy, Desmond G. Powe, Emad A. Rakha, et al.. (2009). Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Research and Treatment. 119(2). 283–293. 187 indexed citations

16.

Habashy, Hany Onsy, Desmond G. Powe, Emad A. Rakha, et al.. (2009). The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype. Breast Cancer Research and Treatment. 120(3). 603–612. 74 indexed citations

17.

Abdel-Fatah, Tarek M., Desmond G. Powe, Zsolt Hodi, et al.. (2008). Morphologic and Molecular Evolutionary Pathways of Low Nuclear Grade Invasive Breast Cancers and Their Putative Precursor Lesions: Further Evidence to Support the Concept of Low Nuclear Grade Breast Neoplasia Family. The American Journal of Surgical Pathology. 32(4). 513–523. 160 indexed citations

18.

Hewitt, Robert E., et al.. (1996). Morphometric evidence that epithelial basement membrane breaks are a feature of both squamous and basal cell carcinomas of the skin. International Journal of Cancer. 66(1). 24–28. 6 indexed citations

19.

Tan, Kevin, Desmond G. Powe, Trevor Gray, David R. Turner, & Robert E. Hewitt. (1995). Regional variations of urokinase‐type plasminogen activator in human colorectal cancer: A quantitative study by image analysis. International Journal of Cancer. 60(3). 308–314. 13 indexed citations

20.

Hewitt, Robert E., Desmond G. Powe, Cathrine Holland, Trevor Gray, & David R. Turner. (1992). Apparent fusion of basement membranes in colorectal carcinoma. International Journal of Cancer. 50(1). 20–25. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact